There are two aspects of pharmaceuticals. The obvious is which
medicine should be prescribed to treat a particular disease.
Another one is that a pharmaceutical is, as a rule, the subject of
a patent. Pharmaceutical products stand aside from other products
because before going to the public, they must go through research,
clinical trials, and registration with the health ministry or other
authorised government bodies. This multi-tiered composite procedure
gave birth to extending the term of patents directed to
pharmaceutical products up to 25 years in many jurisdictions.
This is not a purely straightforward action. Circumstances
surrounding such cases may present difficulties to the patent
owner.